It's probably effective, but just in case it's not as effective as we think, we want as many people in that trial as possible. Bite the bullet and CR as much as is necessary to make sure we get the statistical significance and our primary endpoint is met. If you think the shre price took a beating on this most recent news, wait and see what happens if a Phase 3 trial doesn't meet it's endpoint.
What's the vehicle anyhow?, page-116
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 147750 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 632850 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |